Long-term Prognosis of Acute Pulmonary Oedema--an Ominous Outcome
Overview
Affiliations
Background: Acute pulmonary oedema (APOE) is a major health problem, leading to poor hospital and long-term outcomes. There is a relative paucity of studies describing prognosis of consecutive unsolicited patients diagnosed with APOE and hospitalized in internal medicine departments.
Aims: To describe the clinical profile and outcome (in hospital and 1-year prognosis) of successive unselected patients with APOE, in a prospective observational study.
Methods And Results: The study population included 150 consecutive unsolicited patients (90 men, 60 women; median age 75 years) with APOE all hospitalized in an internal medicine department, in a 900-bed care centre. Ischaemic heart disease (IHD), hypertension and diabetes were present in 85%, 70% and 52% of patients, respectively. The most common precipitating factors for APOE included high blood pressure (29%), rapid atrial fibrillation (29%), unstable angina pectoris (25%), infection (18%) and acute myocardial infarction (MI; 15%). Eighteen patients (12%) died in hospital, with 82% of these deaths attributed to cardiac pump failure. Predictors for an increased in-hospital mortality included: diabetes (P<0.05), orthopnoea (P<0. 05), echocardiographic finding of depressed global left ventricular systolic function (P<0.001), acute MI during hospital stay (P<0.001), hypotension/shock (P<0.05), and the need for mechanical ventilation (P<0.001). After a median hospital stay of 10 days, 132 patients were discharged home. The 1-year mortality was 40%. Only the presence of pleural effusion was found as a predictor for 1-year mortality.
Conclusion: Most patients with APOE in this study are elderly, and have IHD, hypertension, diabetes and a previous history of APOE. The overall mortality is high (in-hospital, 12%: 1-year, 40%). Left ventricular dysfunction was associated with high in-hospital mortality, but not with long-term prognosis.
Shirinsky V Biomedicines. 2025; 13(1).
PMID: 39857586 PMC: 11762819. DOI: 10.3390/biomedicines13010002.
Iyer N, Bryant J, Le T, Grenier J, Thompson R, Chin C Eur Heart J Imaging Methods Pract. 2024; 2(3):qyae089.
PMID: 39296919 PMC: 11408878. DOI: 10.1093/ehjimp/qyae089.
Wang D, Niu Y, Ma Y, Tang L, Zhang Q, Zhang L BMJ Open. 2024; 14(7):e077980.
PMID: 39079916 PMC: 11293410. DOI: 10.1136/bmjopen-2023-077980.
Dragomir L, Marina V, Anghele A, Anghele M, Moscu C Clin Pract. 2024; 14(4):1417-1429.
PMID: 39051308 PMC: 11270415. DOI: 10.3390/clinpract14040114.
Degefu N, Jambo A, Regassa L, Getachew M J Pharm Policy Pract. 2024; 17(1):2309294.
PMID: 38405032 PMC: 10885763. DOI: 10.1080/20523211.2024.2309294.